MAP1LC3B and breast neoplasm: LC3B is used as a reporter in the majority of cellular assays to measure quality and quantity of autophagy [9], and LC3B is heterozygous deleted in ~68% of SOC tumors and ~56% of breast tumors (S2 Fig).